[1]
“Not All Bruton’s Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors”, Can Hematol Today, vol. 5, no. s02, pp. 2–7, May 2026, doi: 10.58931/cht.2026.5s0282.